Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growth
Badreddin Edris(Stanford Medicine), Matt van de Rijn(Stanford University), Stephen B. Willingham(Silvus Technologies (United States)), Kipp Weiskopf(California Institute for Regenerative Medicine), Agnieszka Czechowicz(Boston Children's Hospital), Robert B. West(Stanford University), Thomas Mühlenberg(University of Duisburg-Essen), Humberto Contreras-Trujillo(California Institute for Regenerative Medicine), Irving L. Weissman(Stanford University), Jonathan A. Fletcher(Brigham and Women's Hospital), Jens-Peter Volkmer(Menlo School), Anne Kathrin Volkmer(California Institute for Regenerative Medicine), Kelli Montgomery(Stanford Medicine)
Cited by 55
Related Papers
Stem cells, cancer, and cancer stem cells
|Nature|2001|9.7k
Epigenetic memory in induced pluripotent stem cells
|Nature|2010|2.3k
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
|Nature|2017|2.3k
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
|Proceedings of the National Academy of Sciences|2012|1.6k
Granulocyte–Macrophage Progenitors as Candidate Leukemic Stem Cells in Blast-Crisis CML
|New England Journal of Medicine|2004|1.5k